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Improvement of Storage Medium 
for Cultured Human Retinal 
Pigment Epithelial Cells Using 
Factorial Design
L. Pasovic1,2,3, T. P. Utheim1,4,5,6,7,8, S. Reppe1, A. Z. Khan  1,2, C. J. Jackson4,8, B. Thiede9,  
J. P. Berg1, E. B. Messelt8 & J. R. Eidet  1,5
Storage of human retinal pigment epithelium (hRPE) can contribute to the advancement of cell-based 
RPE replacement therapies. The present study aimed to improve the quality of stored hRPE cultures 
by identifying storage medium additives that, alone or in combination, contribute to enhancing cell 
viability while preserving morphology and phenotype. hRPE cells were cultured in the presence of 
the silk protein sericin until pigmentation. Cells were then stored for 10 days in storage medium plus 
sericin and either one of 46 different additives. Individual effects of each additive on cell viability were 
assessed using epifluorescence microscopy. Factorial design identified promising additive combinations 
by extrapolating their individual effects. Supplementing the storage medium with sericin combined 
with adenosine, L-ascorbic acid and allopurinol resulted in the highest cell viability (98.6 ± 0.5%) after 
storage for three days, as measured by epifluorescence microscopy. Flow cytometry validated the 
findings. Proteomics identified 61 upregulated and 65 downregulated proteins in this storage group 
compared to the unstored control. Transmission electron microscopy demonstrated the presence of 
melanosomes after storage in the optimized medium. We conclude that the combination of adenosine, 
L-ascorbic acid, allopurinol and sericin in minimal essential medium preserves RPE pigmentation while 
maintaining cell viability during storage.
Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world and is charac-
terized by impairment and loss of the retinal pigment epithelium (RPE)1. Due to the lack of treatment options 
for the dry type of AMD, which affects 85% of patients, replacement of the RPE has been proposed as a future 
therapy for this disease2–11. Expectations for the application of RPE transplants to treat retinal diseases are high, 
and several studies have shown that this approach can restore subretinal anatomy and improve visual function2. 
A recent review by Nommiste et al.12 covers several proof-of-principle studies investigating the efficacy of dif-
ferent cell sources and transplantation techniques. The RPE cells used in these studies are derived from primary 
human stem cells, induced pluripotent stem cells and several other sources, and have been transplanted to the 
subretinal space by means of suspensions, strips or patches on coated polymers13,14. While the strategies for cell 
replacement are improving, the production of cell sheets that fulfill the requirements for transplantation is com-
plex15 and will likely lead to centralization of specialized culture laboratories. The ability to store RPE successfully 
is necessary in order to transport the tissue from the culture laboratories to the transplantation clinics and make 
widespread use of RPE replacement therapies possible12. An established storage method would not only allow for 
transportation, but also make quality control and microbiological testing of the tissue possible16. With continued 
improvement of RPE tissue engineering approaches, and more than 20 million patients suffering from AMD 
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worldwide17, an upcoming need for improved storage and transportation methods for cultured RPE is antici-
pated. An above-freezing temperature storage system as suggested by our research group circumvents the need 
for cryoprotectants, which are known to inflict freezing injury to tissues at both high and low cooling rates18–20.
After testing nine different storage temperatures between 4 °C and 37 °C, we found that hRPE cultures stored 
at 4 °C in a storage medium containing 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)- and 
sodium bicarbonate-buffered Minimum Essential Medium (MEM) preserved the greatest number of viable cells 
(unpublished data). An earlier study showed that the addition of 1% sericin to the cell culture medium enhanced 
hRPE cell maturation, most notably by increasing cell pigmentation21. The MEM storage medium is a defined 
basal medium that mainly consists of inorganic salts, vitamins and glucose. We therefore investigated the effects 
of supplementing this medium with many different additives, including sericin to preserve the differentiated state 
of the cells. The effects of the 46 individual supplements on viability of hRPE cell cultures were analyzed after 
ten days of storage at 4 °C. Some additives were selected based on their known or proposed effects on viability or 
antioxidant function in cultures of RPE or other cell types21–32, while others were chosen based on effects demon-
strated in pilot experiments. Most of the additives have, to our knowledge, never been tested in the current set-
ting. The effects of a total of 32 different combinations of the five most promising additives were simulated using a 
factorial design experiment. The single best combination of additives was selected for further study by additional 
experiments to assess its effects on phenotype and morphology.
Results
Effect of Individual and Combined Storage Medium Additives on Viability of hRPE. hRPE were 
seeded in complete EpiCM on Nunclon Δ surface plates and cultured for two days before replacing EpiCM with 
modified DMEM (hereafter named ≪differentiation medium≫) containing 1% sericin for 14 days. The cells 
had then developed pigmentation as demonstrated earlier21, and were stored for 10 days in storage medium plus 
sericin and either one of 46 different additives. The control group, containing sericin, was stored without addi-
tional additives. Cell survival following 10 days of storage in all 47 experimental groups (N = 3) was assessed by 
calcein-acetoxymethyl ester (CAM) fluorescence using ImageJ software to measure the culture well area covered 
by CAM-stained live hRPE cells. The results are presented in Fig. 1. Cells stored in MEM containing 1% sericin 
served as the control. Control cells covered 73.5 ± 22.3% of the culture well area. In comparison, cells that had 
not been stored covered 99.2 ± 0.1% of the culture well area. No single storage medium additive contributed to 
increasing the CAM-stained culture well area significantly compared to the control. One-way ANOVA revealed 
that two additives significantly reduced cell viability (carnosine and glutathione), while the Student’s t-test 
revealed that four additives significantly reduced cell viability (carnosine, glutathione, deferroxamine mesylate 
and protease inhibitor cocktail) compared to the control.
To investigate whether combinations of additives could increase cell viability further, the five additives which 
provided the largest CAM fluorescence area (adenosine, allopurinol, β-glycerophosphate, L-ascorbic acid and 
taurine) were selected for factorial design experiments. Normality of the data was confirmed by Design-Expert, 
as was absence of significant outliers on residuals plots. The data on percentage of cell viability was then power 
transformed as recommended by the Design-Expert software before subsequent analysis. A significant model 
including all possible additive combinations was computed by Design-Expert software (Stat-Ease) using ANOVA 
(P = 0.047). No single additive supplemented individually to the storage medium had a significant impact on 
cell viability in the factorial design experiments. The combined effects of sericin, adenosine, allopurinol and 
L-ascorbic acid, however, provided the highest desirability regarding both CAM-stained culture well area and 
number of dead cells following storage (Figs 2 and 3).
To confirm factorial design results, viability analysis using CAM area calculation was employed for the opti-
mal additive combination (MEM supplemented with sericin, adenosine, allopurinol and L-ascorbic acid). hRPE 
cells (N = 3) were cultured at 37 °C and stored for three days at 4 °C in the optimal additive combination before 
being compared to control cells (N = 6) that had not been stored. Viability was similar between the groups, with 
a mean CAM fluorescence area of 99.2 ± 0.1% for control cells and 98.6 ± 0.5% for stored cells, respectively 
(Fig. 4A,B).
Validation of Viability Data Using Flow Cytometry. The viability of hRPE stored in the optimal mix 
(MEM supplemented with sericin, adenosine, allopurinol and L-ascorbic acid) for three days was validated using 
flow cytometry with propidium iodide (PI) staining. PI passes through permeable cell membranes of dead cells 
and stains double-stranded DNA. PI bound to 3.1 ± 0.5% of control cells and 7.8 ± 2.5% of stored cells (P < 0.05), 
yielding a viability of 96.8 ± 0.5% and 92.1 ± 2.5%, respectively (Fig. 4C). While the difference was statistically 
significant (P = 0.03), these results support the CAM fluorescence area viability data showing only a small change 
in cell loss in cultures stored using the optimal combination of additives.
pH Measurement. pH of the storage medium was assessed using pH indicator paper and demonstrated pH 
in the physiological area (pH = 7.4).
Morphology of Optimal Combination hRPE. Both light microscopy, scanning electron microscopy and 
transmission electron microscopy were performed to investigate the effect of the optimal combination of stor-
age medium additives on the morphology of hRPE. Control cells were cultured to confluence and obtained the 
characteristic morphology comprising a hexagonal cell shape and cytoplasmic pigmentation (Fig. 5). The same 
features were observed in hRPE cells that had been stored for three days using the optimal combination of storage 
medium additives, indicating that hRPE can be stored in this additive combination while retaining a classic RPE 
morphology.
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Transmission electron microscopy demonstrated that the degree of melanization in cells stored in the optimal 
additive combination maintained or even exceeded that of control cells (Fig. 6A–E), thereby supporting the find-
ings made by light microscopy. Intercellular tight junctions were present both between control cells and between 
cells stored in the optimal additive combination (Fig. 6B,D). Microvilli were demonstrated in both groups, both 
by transmission and scanning electron microscopy (Fig. 6A,B,F,G).
Proteomic Analysis of hRPE Using the Optimal Additive Combination. Proteomic analysis was 
performed to investigate the effect of the optimal combination of storage medium additives on the hRPE pro-
teome. hRPE cells stored in the optimal storage medium combination were compared to control cells that had not 
been stored. Of 3902 identified proteins, 126 were differentially expressed applying t-test with P < 0.05 (Tables 1 
and 2). A total of 65 proteins (1.7%) were downregulated during storage for three days in the optimal additive 
mix, while 61 proteins (1.6%) were upregulated during storage in the optimal additive mix (Fig. 7). The distribu-
tion of differentially expressed proteins was similar between the groups (Fig. 8).
The cytoskeleton-related proteins ezrin and desmoplakin, and perioxiredoxins 2 and 3, important antioxi-
dant enzymes of the cytosol and mitochondria, respectively33, were upregulated during storage. Expression of 
vinculin and microtubule-associated protein 4 was reduced during storage. Vinculin is a membrane-associated 
protein that functions as a multiprotein linker to the actin cytoskeleton34, while microtubule-associated protein 4 
is involved in crosslinking of microtubules to actin filaments35. The expression levels of several proteins associated 
Figure 1. Cell viability after ten days of storage as measured by area of CAM fluorescence. The control line 
drawn from the black diamond represents the area of calcein-acetoxymethyl ester (CAM) fluorescence 
obtained in the control group (N = 18), where 1% sericin was added to the MEM-based storage medium. 
Other bar points are representations of CAM area fluorescence for each additive (N = 3) supplemented to 
MEM in the presence of 1% sericin. Resulting effects are displayed as either increasing or decreasing CAM area 
fluorescence compared to the control line. The addition of carnosine, deferroxamine mesylate, glutathione or 
the protease inhibitor cocktail to the storage medium significantly reduces cell viability as measured by CAM 
area fluorescence (*, P < 0.05). Error bars represent the standard deviation of mean values. BSA: bovine serum 
albumin; DADLE: [D-Ala2, D-Leu5]-Enkephalin; DHA: docosahexaenoic acid; HGF: hepatocyte growth factor; 
IGF1: insulin-like growth factor 1; JSH-23: 4-methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine; PEDF: 
pigment epithelium-derived factor.
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with important RPE functions were specifically analyzed. The list of proteins was selected based on their known 
roles in visual pigment generation, phagocytosis and adhesion of RPE36–40. Only one of the selected proteins 
important for specific RPE functions had significantly changed regulation in the stored cells compared to the 
control (Table 3). Tyrosinase was slightly, but significantly downregulated in stored cells compared to control cells 
(fold change 0.8; P < 0.01).
Discussion
The present study indicates that the storage viability of hRPE cells can be increased by supplementing the 
serum-free MEM-based storage medium containing sericin with a combination of three additional additives, 
while maintaining a differentiated morphology and with only slight phenotypic changes. A total of 47 individual 
Figure 2. Factorial design analysis. Factorial design analysis of the five most promising additives providing a 
ramp display showing individual graphs for each additive in the most desirable storage medium combination. 
Presence of additive was set as “1”, while absence of additive was set as “−1”. The dot on each ramp represents 
the factor setting or response prediction for the resulting combination.
Figure 3. Cube plot illustrating the predicted response as a function of the three additives that created the 
most desirable effect. The plot shows how three factors (B, D, E) combine to affect the response. All values 
are predicted. Maximum desirability is reached at settings B+ , D+ and E+ (allopurinol, L-ascorbic acid and 
adenosine).
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additives were studied, including 32 combinations of the five most promising additives using a full-factorial design 
experiment. Herein, the five most promising storage media additives (adenosine, allopurinol, β-glycerophosphate, 
L-ascorbic acid and taurine) were investigated simultaneously. Compared to one-factor-at-a-time (OFAT) stud-
ies, factorial experiments have several advantages41. First, they require less time, material, and number of exper-
iments, making them more cost-effective. Second, they yield better estimates of the effects of each factor because 
all observations are used to calculate the effect of each individual variable. Third, they reveal interactions between 
factors and thus permit the exploration of optimal combinations over the entire repertoire of substances. Hence, 
Figure 4. Viability of hRPE stored in the optimal combination of storage medium additives for three days. 
hRPE were analyzed by (A,B) quantitative fluorescence and (C) flow cytometry. (A) Cell viability as measured 
by area of calcein-acetoxymethyl ester (CAM) fluorescence, demonstrating similar results between groups 
(N = 6). Error bars represent the standard deviation of mean values. (B) Representative photomicrographs 
demonstrating similar CAM labeling between groups. (C) Representative flow cytometry plots of dead cells 
by propidium iodide exclusion in control cells and cells stored for three days (N = 3). The plots demonstrate a 
relatively low cell death rate in the stored group.
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compared to OFAT studies, which vary only one factor at a time, factorial experiments simultaneously inspecting 
several factors are far more efficient when analyzing the effect of two or more variables.
The full-factorial experiment revealed that adenosine, allopurinol and L-ascorbic acid together provided the 
most desirable additive combination with regard to cell viability. This finding was controlled using CAM fluores-
cence measurements and validated by flow cytometry. The combined effects of these additives on hRPE storage 
have not been described earlier, but their individual effects on many cellular processes have been widely stud-
ied. Adenosine is a purine nucleoside which has been shown to participate in the regulation of inflammatory 
responses by limiting inflammatory tissue destruction42. Adenosine binds G protein-coupled adenosine recep-
tors43, and A3 receptor activation has been demonstrated to protect retinal cultures against neurodegeneration44. 
Activation of the ATP receptor P2X7 is known to induce death of retinal ganglion cells, but simultaneous intravit-
real injection of an A3 receptor agonist can prevent the P2X7-associated cell death45. P2X7 overactivation results 
in dysregulated calcium signaling and is involved in the age-related dysfunction and degeneration of RPE cells46. 
This suggests that overactive purinergic signaling may contribute to the geographic atrophy seen in dry AMD47. 
The activation of adenosine receptors and inhibition of P2X7 is considered clinically relevant for the prevention 
of cell death in several eye diseases, including AMD47. Whether the beneficial effect of adenosine on preventing 
P2X7-associated cell death is responsible for providing increased hRPE cell viability, or other mechanisms are at 
play, warrants further study.
Allopurinol is a xanthine oxidase inhibitor that reduces the production of uric acid and is being investigated for 
management of reperfusion injury. It has been shown to prevent postasphyxial changes in newborn pig retinas48 
and has been successfully used in the treatment of autoimmune uveitis in an experimental setting49. Allopurinol 
administered to RPE cell cultures in high doses has been demonstrated to prevent free-radical-induced cell dam-
age50. Its proposed effect on quenching free radicals might have contributed to enhancing cell viability of cultured 
hRPE cells during storage in the present study.
It has been established that high levels of antioxidant vitamins can significantly reduce the risk of advanced 
AMD and its associated vision loss in patients with intermediate or advanced AMD51. The addition of ascorbic 
acid to primary RPE cell cultures in vitro has been demonstrated to provide a dose-related downregulation of 
early-response proteins that are triggered by oxidative stress52. In a study using the RPE cell line ARPE-19, how-
ever, ascorbic acid was not shown to protect the cells from hydroxyl radical induced cell death53. Yet other studies 
have shown that ascorbic acid supplementation can protect RPE cells from hypoxic damage54 and reduce vision 
cell loss from damaging light55. However, the latter effect might be attributable to ascorbic acid preventing exces-
sive shedding of rod outer segments upon light exposure56. The effect of ascorbic acid in the present study might 
be similar to that of allopurinol in that it reduces the oxidative stress burden.
Our research group recently demonstrated that sericin induces melanogenesis of hRPE cells through activa-
tion of the NF-κB pathway21. Sericin has been shown to inhibit tyrosinase57, and proteomic analysis in the present 
study confirmed that tyrosinase expression is slightly reduced in cells stored in the optimal additive combina-
tion in the presence of sericin. The expression of other pigment-related proteins (premelanosome protein 17, 
Figure 5. Representative sample from light microscopy observations before and after three days of storage 
using the best additive combination. The photomicrographs reflect the presence of melanized hRPE cells in both 
groups and show the classic hexagonal distribution of mature hRPE monolayers.
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tyrosinase related protein 1 and tyrosinase related protein 2) was maintained during storage using the optimal 
additive combination. Tyrosinase is the main rate-limiting melanogenesis enzyme, catalyzing the formation of 
dihydroxyphenylalanine (L-DOPA) from L-tyrosine58. However, light microscopy and TEM demonstrated the 
presence of melanized cells and melanosomes in stored cell cultures. While phase contrast and transmission 
electron microscopy can determine the presence of melanosomes, these are not satisfactory methods by which to 
objectively determine the level of pigmentation. Future studies warrant the use of other methods, i.e. spectropho-
tometry or modified scanning devices as demonstrated by Lane et al.59.
In a study by Vugler et al.60 investigating RPE cells differentiated from human embryonal stem cells 
(HESC-RPE), a larger number of stage 4 melanosomes were displayed; however, these cells were of a different ori-
gin and were cultured under very different conditions than used in the present study. For instance, the HESC-RPE 
were cultured on Matrigel for five weeks. Polarization was evident with basally oriented nuclei like in our cells, 
but apical microvilli were more developed in this study than is shown in our cultures. Both the cell source and 
culture length might be of essence in order to further enhance differentiation61–63. Ultrastructure is presented in 
great detail in a study by Carr et al.64, who demonstrated that co-culture of HESC-RPE with human retina leads 
to maturation-associated morphological alterations. Herein, the presence of melanosomes, tight junctions and 
microvilli is demonstrated. Similar findings are made in control cells and cells stored in the optimal additive 
combination in this study (Fig. 6).
Figure 6. Ultrastructure of stored hRPE cells compared to control. Transmission and scanning electron 
microscope photomicrographs of control cells that have not been stored (A–C,F) and hRPE cells that have 
been stored at 4 °C in the optimal additive combination for three days (D,E,G). Intercellular tight junctions are 
present both between control cells and between cells stored in the optimal additive combination (white arrows 
in B,D). Microvilli are present in both groups, demonstrated both by transmission and scanning electron 
microscopy (black arrows in A,B,F,G). Photomicrographs C and E demonstrate the presence of melanosomes 
at stage III (some melanin pigment deposited onto internal striations) in the control group and stage III and IV 
(fully melanized) in the storage group. Cell borders are indicated by white arrows (F,G).
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Gene 
Symbol Gene Description Biological function
ACOX1 Peroxisomal acyl-coenzyme A oxidase 1 Desaturation of acyl-CoAs to 2-trans-enoyl-CoAs
ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase Synthesis of proline, ornithine and arginine
AP2A1 AP-2 complex subunit alpha-1 Component of the adaptor protein complex 2; clathrin-dependent endocytosis
ARHGAP1 Rho GTPase-activating protein 1 GTPase activator for Rho, Rac and Cdc42
ARMT1 Protein-glutamate O-methyltransferase Formation of gamma-glutamyl methyl ester residues
BCLAF1 Bcl-2-associated transcription factor 1 Death-promoting transcriptional repressor
DAZAP1 DAZ-associated protein 1 RNA-binding protein; possibly required in spermatogenesis
DBI Acyl-CoA-binding protein Possible intracellular carrier of acyl-CoA esters
DBT Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial Conversion of alpha-keto acids to acyl-CoA and CO2
DDX23 Probable ATP-dependent RNA helicase DDX23 Pre-mRNA splicing
DNAJC3 DnaJ homolog subfamily C member 3 Unfolded protein response during endoplasmic reticulum stress
DSP Desmoplakin Anchoring of intermediate filaments to desmosomes
EIF6 Eukaryotic translation initiation factor 6 Prevents the association of the 60S ribosomal subunit with the 40S subunit
EPM2AIP1 EPM2A-interacting protein 1 Unknown
EZR Ezrin Connection of cytoskeletal structures to the plasma membrane; formation of microvilli
FARSB Phenylalanine–tRNA ligase beta subunit Regulatory tRNA ligase beta subunit
FBN2 Fibrillin-2 Component of extracellular calcium-binding microfibrils; regulation of elastic fibers
FLOT1 Flotillin-1 Possible scaffolding protein within caveolar membranes; formation of caveolae
FUCA2 Plasma alpha-L-fucosidase Hydrolyzation of glycoproteins
GATM Glycine amidinotransferase, mitochondrial Synthesis of creatine precursor guanidinoacetate
GDAP2 Ganglioside-induced differentiation-associated protein 2 Unknown
HIST1H4A Histone H4 Core nucleosome component
HNRNPD Heterogeneous nuclear ribonucleoprotein D0 RNA-binding protein
HNRNPH1 Heterogeneous nuclear ribonucleoprotein H Pre-mRNA processing
HNRNPM Heterogeneous nuclear ribonucleoprotein M Pre-mRNA binding protein
HSD17B2 Estradiol 17-beta-dehydrogenase 2 Interconversion of testosterone and androstenedione; estradiol and estrone
KIAA1468 LisH domain and HEAT repeat-containing protein KIAA1468 Unknown
KTN1 Kinectin Kinesin-driven vesicle motility
LRPPRC Leucine-rich PPR motif-containing protein, mitochondrial Nuclear and mitochondrial RNA metabolism
LRRC8A Volume-regulated anion channel subunit LRRC8A Essential component of the volume-regulated anion channel
LRSAM1 E3 ubiquitin-protein ligase LRSAM1
Regulation of signaling pathways, cell adhesion, 
self-ubiquitylation, and cargo sorting during receptor 
endocytosis
MRPL28 39S ribosomal protein L28, mitochondrial Component of the 39S mitochondrial ribosome subunit
MRRF Ribosome-recycling factor, mitochondrial Release of ribosomes from mRNA
MYH9 Myosin-9 Cytokinesis, cell shape, secretion
MYO7A Unconventional myosin-VIIa Intracellular movements
NUDT19 Nucleoside diphosphate-linked moiety X motif 19 Hydrolysis various CoA esters
NUP155 Nuclear pore complex protein Nup155 Component of the nuclear pore complex
PDHB Pyruvate dehydrogenase E1 component subunit beta, mitochondrial Conversion of pyruvate to acetyl-CoA and CO2
POLR2E DNA-directed RNA polymerases I, II, and III subunit RPABC1 Subunit of RNA polymerase II
PRCP Lysosomal Pro-X carboxypeptidase Cleavage of C-terminal amino acids
PRDX2 Peroxiredoxin-2 Involved in redox regulation of the cell
PRDX3 Thioredoxin-dependent peroxide reductase, mitochondrial Involved in redox regulation of the cell
PRKCSH Glucosidase 2 subunit beta Beta-subunit of glucosidase II, an ER glycan-processing enzyme
PRKDC DNA-dependent protein kinase catalytic subunit DNA double-strand break repair
PRPF8 Pre-mRNA-processing-splicing factor 8 Assembly of spliceosomal proteins
PRPS2 Ribose-phosphate pyrophosphokinase 2 Synthesis of phosphoribosylpyrophosphate (PRPP), essential for nucleotide synthesis
Continued
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Pyruvate has been shown to induce pigmentation of ARPE-19 cells cultured in DMEM with high glucose61. In 
our study, the basic storage medium was supplemented with pyruvate, which might have contributed further to 
the increased pigmentation demonstrated in both the current and earlier studies by our research group. Although 
several culture protocols using hESCs or iPSCs have successfully produced differentiated and pigmented RPE 
cells, they are usually more time-consuming62,63. The use of sericin might contribute in shortening the culture 
period. The focus on the differentiation process is critical, as its efficiency is considered crucial to the economic 
feasibility of regenerative therapy using RPE cells59.
The expression of the tight junction protein ZO-1 was maintained during storage, as demonstrated by pro-
teomics analysis and transmission electron microscopy. Cultured cells established the classic hexagonal distribu-
tion of mature hRPE monolayers. The RPE, being a polarized monolayer, is dependent on functional intercellular 
tight junctions to maintain high transepithelial resistance, secure cellular barrier function and regulate paracel-
lular permeability65–68. Hence, the present study confirms earlier findings, but still indicates that hRPE cells can 
retain features of a mature phenotype when stored in the optimal additive combination.
The cytoskeleton-related proteins ezrin and desmoplakin were upregulated during storage. Ezrin is a cortical 
cytoskeleton protein which localizes to epithelial microvilli69. Loss of ezrin function as demonstrated in ezrin 
knockout mice leads to substantial reduction in RPE apical microvilli and retarded photoreceptor development69. 
Desmoplakin is necessary for the anchoring of keratin at cell-cell contacts70, and thus important for the regulation 
of desmosomal adhesion strength71. It functions as a tumor suppressor72, and a decrease in desmosomal protein 
expression is associated with poor prognosis in several cancers73–75. Loss-of-function mutations in desmosomal 
proteins have been associated with clinical syndromes involving the skin, heart, hair and immune system76–79. 
Upregulation of these proteins during storage might indicate that stored cells maintain robust cytoskeletal 
functions.
Third passage hRPE cells were employed in this study. The increased tendency of epithelial to mesenchymal 
transition with increasing passages of RPE cells has been demonstrated by Grisanti et al. They showed a large dis-
parity between passage 2 RPE and passage 10 RPE, where cells of the higher passages transdifferentiate and lose 
differentiated RPE properties80. While there is a wide consensus regarding the advantages of using early-passage 
RPE cells to avoid this phenomenon in culture, an exact passage number has not been defined. In a study by 
Ganti et al. investigating vitreous modulation of gene expression in low-passage hRPE, cells from passages 3–6 
were termed “early-passage”81. Based on the observed benefits of early passage cell lines, we selected third passage 
hRPE cells for this study.
In conclusion, the current study demonstrates that the storage medium additive combination of sericin, aden-
osine, allopurinol and L-ascorbic acid successfully maintains hRPE cell viability during storage while preserving 
the characteristic hRPE morphology and proteome. The effects of the individual additives are not thoroughly 
understood, but previous research points to free radical scavenging mechanisms as possible explanations for 
these findings.
Future studies should investigate the effect of increased storage duration on hRPE cells in the optimal combi-
nation medium, and ideally expand the scope to RPE derived from different sources, including primary human 
stem cells and induced pluripotent stem cells. This could provide valuable knowledge when establishing a storage 
protocol for clinical use.
Gene 
Symbol Gene Description Biological function
PTCD3 Pentatricopeptide repeat domain-containing protein 3, mitochondrial Mitochondrial RNA-binding protein
PTPRA Receptor-type tyrosine-protein phosphatase alpha Regulation of integrin signaling, cell adhesion and proliferation
RAB7A Ras-related protein Rab-7a Key regulator in endo-lysosomal trafficking
RPL18 60S ribosomal protein L18 Component of the ribosomal 60S subunit
RPL37A 60S ribosomal protein L37a Component of the ribosomal 60S subunit
SLC25A3 Phosphate carrier protein, mitochondrial Transport of phosphate groups from the cytosol to the mitochondrial matrix
SOSTDC1 Sclerostin domain-containing protein 1 Bone morphogenetic protein antagonist
SRP54 Signal recognition particle 54 kDa protein Transfer of presecretory protein from ribosomes to TRAM (translocating chain-associating membrane protein)
STAG2 Cohesin subunit SA-2 Component of the cohesin complex
SUCLG2 Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial Citric acid cycle
SULT1A1 Sulfotransferase 1A1 Sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters
TOR1A Torsin-1A Protein folding, processing, stability and localization
TRA2B Transformer-2 protein homolog beta Pre-mRNA splicing
UBA1 Ubiquitin-like modifier-activating enzyme 1 Ubiquitin conjugation
VPS18 Vacuolar protein sorting-associated protein 18 homolog Vesicle-mediated protein trafficking to lysosomal compartments
Table 1. Significantly upregulated proteins during storage (low in control cells).
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Gene 
Symbol Gene Description Biological function
ABCA1 ATP-binding cassette sub-family A member 1 Transmembrane transport
ATP1A1 Sodium/potassium-transporting ATPase subunit alpha-1
Hydrolysis of ATP coupled with the exchange of sodium and 
potassium ions across the plasma membrane
ATP1A3 Sodium/potassium-transporting ATPase subunit alpha-3
Hydrolysis of ATP coupled with the exchange of sodium and 
potassium ions across the plasma membrane
ATP6V1C2 V-type proton ATPase subunit C 2 Subunit of the vacuolar ATPase
CD2AP CD2-associated protein Adapter protein between membrane proteins and the actin cytoskeleton
COASY Bifunctional coenzyme A synthase CoA biosynthetic pathway
COPZ1 Coatomer subunit zeta-1 Binds dilysine motifs, reversibly associates with Golgi non-clathrin-coated vesicles
CTTN Src substrate cortactin Organization of the actin cytoskeleton
EIF2S2 Eukaryotic translation initiation factor 2 subunit 2 Early protein synthesis
EIF4A3 Eukaryotic initiation factor 4A-III ATP-dependent RNA helicase
FAH Fumarylacetoacetase Tyrosine catabolism
FAM234A Protein ITFG3/Protein FAM234A Unknown
FERMT2 Fermitin family homolog 2 Scaffolding protein, activates integrin
FNDC3A Fibronectin type-III domain-containing protein 3A Spermatid-Sertoli adhesion in spermatogenesis
G3BP2 Ras GTPase-activating protein-binding protein 2 Probable scaffold protein, may be involved in mRNA transport
GDI2 Rab GDP dissociation inhibitor beta Regulates the GDP/GTP exchange reaction of Rab proteins
GLYR1 Putative oxidoreductase GLYR1 Promotes KDM1B demethylase activity
GNPDA1 Glucosamine-6-phosphate isomerase 1 Conversion of D-glucosamine-6-phosphate into D-fructose-6-phosphate and ammonium
GOLM1 Golgi membrane protein 1 Unknown
GPX8 Probable glutathione peroxidase 8 Unknown
HDDC2 HD domain-containing protein 2 Unknown
HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 Mitochondrial tRNA maturation
KIF5B Kinesin-1 heavy chain Distribution of mitochondria and lysosomes
KPNA2 Importin subunit alpha-1 Nuclear protein import
KPNB1 Importin subunit beta-1 Nuclear protein import
LDHB L-lactate dehydrogenase B chain Synthesizes lactate from pyruvate
LIMCH1 LIM and calponin homology domains-containing protein 1 Unknown
LPL Lipoprotein lipase Hydrolysis of triglycerides of chylomicrons and very low density lipoproteins
LRRN1 Leucine-rich repeat neuronal protein 1 Unknown
MAP4 Microtubule-associated protein 4 Promotes microtubule assembly
MARS Methionine–tRNA ligase, cytoplasmic Ligation of methionine to tRNA molecules
MAT2B Methionine adenosyltransferase 2 subunit beta Regulatory subunit of S-adenosylmethionine synthetase 2
MPI Mannose-6-phosphate isomerase Mannosyl transfer reactions
MRPL2 39 S ribosomal protein L2, mitochondrial Component of the 39 S mitochondrial ribosome subunit
MYO1D Unconventional myosin-Id Intracellular movement
MYRIP Rab effector MyRIP Melanosome transport
NDUFB3 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 Mitochondrial respiratory chain NADH dehydrogenase
NHP2 H/ACA ribonucleoprotein complex subunit 2 Ribosome biogenesis
NOV Protein NOV homolog Cell proliferation, adhesion, differentiation
PARK7 Protein DJ-1 Oxidative stress and cell death protection
PDAP1 28 kDa heat- and acid-stable phosphoprotein PDGFA-stimulated fibroblast growth
PLS3 Plastin-3 Actin-bundling protein of intestinal microvilli, stereocilia, fibroblast filopodia
RABGAP1 Rab GTPase-activating protein 1 Unknown
RHOT2 Mitochondrial Rho GTPase 2 Mitochondrial trafficking
RPS13 40S ribosomal protein S13 Component of the ribosomal 40S subunit
RTCB tRNA-splicing ligase RtcB homolog Subunit of tRNA-splicing ligase
SCPEP1 Retinoid-inducible serine carboxypeptidase Unknown
SEC23B Protein transport protein Sec. 23B ER-derived vesicle transport
SLC1A5 Neutral amino acid transporter B(0) Sodium-dependent amino acid transport
Continued
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Methods
Supplies. Primary hRPE and complete epithelial cell medium (EpiCM) were purchased from ScienCell 
Research Laboratories (San Diego, CA). Dulbecco’s Modified Eagle’s Medium (high glucose, with pyruvate; 
hereafter named DMEM), Minimal Essential Medium, heat-inactivated fetal bovine serum (FBS), N1 growth 
supplement, taurine, triiodothyronine, non-essential amino acids, glutamine-penicillin-streptomycin, hydro-
cortisone, propidium iodide (PI), phosphate-buffered saline (PBS) and 4′,6-diamidino-2-phenylindole (DAPI) 
were obtained from Sigma Aldrich (St Louis, MO). Nunclon Δ surface plates, pipettes and other routine plastics 
were purchased from VWR International (West Chester, PA). The calcein-acetoxymethyl ester (CAM)/ethidium 
homodimer 1 (EH-1) viability kit was purchased from Invitrogen. The 47 additives used in the study are listed in 
Supplementary Information, Table S1.
Culture and Preparation of Cells. Third passage hRPE were seeded (20,000 cells/cm2) in complete EpiCM 
on 96-well Nunclon Δ surface plates and cultured under routine conditions of 95% air and 5% CO2 at 37 °C. After 
two days, EpiCM was replaced with modified DMEM (hereafter named «differentiation medium») containing 
4.5 g/L glucose, pyruvate, 1% sericin, and 1% penicillin-streptomycin. Cells were then cultured for 14 days in dif-
ferentiation medium until pigmentation, as demonstrated in an earlier study21. The culture medium was changed 
every two or three days.
Storage of hRPE cells. Cells were cultured in the differentiation medium for 14 days, until cells were con-
fluent and >20% of cells were pigmented as visually determined by phase contrast microscopy. The differentiation 
Gene 
Symbol Gene Description Biological function
SLC7A5 Large neutral amino acids transporter small subunit 1 L-leucine transport across the blood-retinal barrier
SMARCD1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 Chromatin remodeling
SPR Sepiapterin reductase Reduction of pteridine derivatives
TKFC Triokinase/FMN cyclase Dihydroxyacetone phosphorylation
TNKS1BP1 182 kDa tankyrase-1-binding protein Colocalizes with chromosomes in mitosis
TPRN Taperin Sensory epithelial protein associated with autosomal recessive deafness.
TSPAN4 Tetraspanin-4 Cell surface glycoprotein binding to integrin
TWF2 Twinfilin-2 Actin-binding protein involved in motile and morphological processes
TXNL1 Thioredoxin-like protein 1 Active thioredoxin
TYR Tyrosinase Formation of pigments, melanin production from tyrosine
UBE2O E2 ubiquitin-conjugating enzyme Monoubiquitination of target proteins
UNC13D Protein unc-13 homolog D Vesicle maturation during exocytosis
USP5 Ubiquitin carboxyl-terminal hydrolase 5 Cleaves multiubiquitin polymers
VCL Vinculin Actin binding protein involved in cell-matrix adhesion and cell-cell adhesion
VPS25 Vacuolar protein-sorting-associated protein 25 Sorting of ubiquitinated membrane proteins during endocytosis
YAP1 Transcriptional coactivator YAP1 Critical regulatory target of the Hippo signaling pathway
Table 2. Significantly downregulated proteins during storage (high in control cells).
Figure 7. Protein expression in experimental groups. Venn diagram showing the distribution of proteins that 
are highly expressed in control cells, stored cells, and those which are statistically insignificant.
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Figure 8. Distribution of protein functions. Gene ontology pie chart showing the distribution of protein 
functions in hRPE before (A) and after (B) storage according to their molecular functions as determined using 
Scaffold software with NCBI annotations.
Gene Symbol Gene Description Role in RPE Fold change P value (T test)
RPE65 Retinoid isomerohydrolase Visual pigment regeneration 1.1 0.21
RLBP1 (CRALBP) Retinaldehyde-binding protein 1 Visual cycle 1 0.93
TYR Tyrosinase Pigmentation 0.8 0.0038
PMEL Melanocyte protein PMEL Pigmentation 1 0.65
TYRP1 5,6-dihydroxyindole-2-carboxylic acid oxidase Pigmentation 0.9 0.32
TYRP2 L-dopachrome tautomerase Pigmentation 0.8 0.23
MFGE8 Lactadherin Phagocytosis 1 0.81
ZO-1 Tight junction protein ZO-1 Tight junctions 1 0.90
OCLN Occludin Tight junctions 0.9 0.75
KRT18 Keratin, type I cytoskeletal 18 Cytoskeleton 0.9 0.08
Table 3. Effect of storage on the expression of some proteins associated with RPE-specific functions. Fold 
change represents changes in cells stored for three days compared to control cells.
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medium was then removed and the cultures were rinsed with PBS before addition of storage medium. The storage 
medium consisted of 0.3 mL MEM, 25 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES), 
22.3 mM sodium bicarbonate, 50 µg/mL gentamycin, and 1% sericin. A total of 46 different additives were indi-
vidually supplemented to the storage medium and sterile-filtered (pore size 0.2 μm) before being added to the 
culture wells (N = 3) using a Biomek® 4000 Laboratory Automation Workstation (Beckman Coulter, Inc., Brea, 
CA). All cultures were stored at 4 °C for ten days, without change or addition of storage medium. The storage 
containers were custom-built as reported elsewhere82. pH measurements of the storage medium were performed 
using pH indicator paper.
Viability Analysis using Quantitative Immunofluorescence. Cell viability was analyzed after 10 days 
of storage by incubating the stored cells with PBS containing 1.0 μM CAM and 1.0 μM EH-1 for 30 min. CAM 
is enzymatically cleaved into the green fluorescent calcein inside living cells. EH-1 is a membrane-impermeable 
dye that binds to DNA of dead cells. Area of fluorescence was calculated for all additive groups using epifluo-
rescence microscopy and custom-made macros with ImageJ software (National Institutes of Health, Bethesda, 
MD). In detail, photomicrographs were captured at 200x magnification at five predetermined locations in each 
culture well using a Nikon Eclipse Ti fluorescence microscope (Nikon Instruments, Tokyo, Japan) with a DS-Qi1 
black-and-white camera (Nikon Instruments) and a motorized microscope stage. Identical exposure length and 
gain were used for all compared groups, while keeping the image brightness within the camera’s dynamic range.
ImageJ software was used to subtract unevenly transmitted light from all 16-bit photomicrographs using the 
“Subtract Background” -command. All photomicrographs were converted to binary photos before the “Area 
Fraction” -command was used to measure the culture well area covered by CAM-stained cells. The number of 
EH-1 stained nuclei was automatically counted using the “Analyze Particles” -command (Fig. 9).
Factorial Design. A factorial design experiment is a complex statistical design offering the possibility to 
study more than one factor at a time by creating a simulation of combined factor effects. Factorial design using 
Design-Expert (Stat-Ease, Inc., Minneapolis, MN) was employed to identify the most promising combination 
of storage medium additives. The five best additives from the viability analysis were included as independent 
variables (adenosine, allopurinol, β-glycerophosphate, L-ascorbic acid and taurine), with area of CAM fluores-
cence and the number of dead cells as the two dependent variables. The combined results of two end points were 
studied. However, the «Importance» tool was employed to set relative priorities for the two variables. The impor-
tance of viability (CAM fluorescence area) was emphasized over cell death (number of dead cells). The two-level 
full-factorial design included replicates of all 32 possible combinations of the five additives. Data were fitted to a 
full quadratic model. ANOVA was used to calculate the adjusted significance of both models (viability and death) 
in Design-Expert (P = 0.0047 and P = 0.036, respectively).
Flow Cytometry. Flow cytometry was used to validate the viability results. Cells were cultured in T25 cell 
culture flasks following the aforementioned protocol. Control cells (N = 3) and cells stored in the optimal additive 
combination (1% sericin, 5 mmol/L adenosine, 50 μg/mL L-ascorbic acid and 1 mM allopurinol) (N = 3) for three 
days were compared. Propidium iodide (PI), which binds to double-stranded DNA of dead cells, was added to 
the culture medium of both culture groups at a concentration of 2.5 μg/300 μL sample and cells were returned 
to the incubator for 15 minutes. Cells were then rinsed with PBS, trypsinized for 2–3 minutes, then washed and 
re-suspended in ice-cold HBSS +4% FBS. Samples were kept on ice and analyzed using the BD Accuri C6 bench 
top flow cytometer. PI is excited by the 588 nm laser and is detected in filter 616//23 (FL3).
Transmission Electron Microscopy. Both unstored cultures and samples of hRPE stored for three days 
in MEM storage medium with the optimal additive combination (1% sericin, 5 mmol/L adenosine, 50 μg/mL 
L-ascorbic acid and 1 mM allopurinol) were processed for transmission electron microscopy (TEM) analysis 
as described earlier83. In essence, a Leica Ultracut Ultramicrotome (Leixa, Wetzlar, Germany) was used to cut 
ultrathin sections, which were examined using a CM120 transmission electron microscope (Philips, Amsterdam, 
the Netherlands).
Statistical Analysis. Statistical analysis was performed using IBM SPSS Statistics for Macintosh version 
22.0 (IBM Corp, Armonk, NY). A one-way analysis of variance with Tukey’s post-hoc comparisons was used for 
statistical evaluation of the viability results. The Student’s t-test was used to compare two groups. P values below 
0.05 were considered significant.
Proteomics. The proteome of hRPE cells stored in the optimal storage medium combination was analyzed 
and compared to control cells that had not been stored. The proteome analyses were performed as previously 
described84. Briefly, the proteins of cell lysates were digested in-solution with trypsin. The generated peptides 
were analyzed by LC-MS using a nano-UHPLC connected to a Q Exactive mass spectrometer. Proteins were 
identified using the Mascot search engine and Scaffold software (version Scaffold_4.7.3, Proteome Software Inc., 
Portland, OR) was used for further data analysis and label-free quantification. Scaffold was used to validate MS/
MS based peptide and protein identifications. Peptide identifications were accepted if they could be established 
at greater than 95.0% probability by the Peptide Prophet algorithm85 with Scaffold delta-mass correction. Protein 
identifications were accepted if they could be established at greater than 99.0% probability and contained at least 
2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm86. Proteins that con-
tained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the 
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principles of parsimony. Distribution of protein functions in hRPE before and after storage was determined using 
Scaffold software with annotations downloaded from the NCBI web database.
Data availability. The datasets generated and analyzed during the current study are available from the cor-
responding author on request.
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